LB Pharmaceuticals

Recent news

• Rating change
  Craig-Hallum Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)
  TipRanks · 2026/5/13
• Rating change
  Piper Sandler Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $78
  Market Newswire · 2026/8/3
• Rating change
  Wolfe Research Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
  Market Newswire · 2026/7/7
• Needham Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $68
  Market Newswire · 2026/10/2
• Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $69
  Market Newswire · 2026/8/21
• Rating change
  Stifel Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $53
  Market Newswire · 2026/8/13
• Rating change
  Roth MKM Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $37
  Market Newswire · 2026/5/18
• Rating change
  Analysts Offer Insights on NA Companies: Exodus Movement, Inc. Class A (EXOD) and LB Pharmaceuticals, Inc. (LBRX)
  TipRanks · 2026/7/22
• Rating change
  Clear Street Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
  Market Newswire · 2026/5/27
• Rating change
  LB Pharmaceuticals, Inc. (LBRX) Gets a Buy From H.C. Wainwright
  TipRanks · 2026/6/25
• Rating change
  Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX)
  TipRanks · 2026/8/3
• Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, Vs. FactSet Est of $0.81 Loss
  MT Newswires · 2026/8/11
• Rating change
  Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)
  TipRanks · 2026/8/12
• H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $60
  Market Newswire · 2026/8/24
• Rating change
  Roth MKM Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $37
  Market Newswire · 2026/5/18
• Rating change
  H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2026/8/3
• Rating change
  Craig-Hallum Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $36
  Market Newswire · 2026/5/13
• Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $69
  Market Newswire · 2026/8/21
• Rating change
  Craig-Hallum Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $36
  Market Newswire · 2026/6/11
• Rating change
  Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX), LB Pharmaceuticals, Inc. (LBRX) and BETA Technologies, Inc. Class A (BETA)
  TipRanks · 2026/8/13

Headlines are aggregated automatically and are not independently verified or edited by our team.